Abstract
Bone has been used as an image guidance surrogate for prostate and pelvic lymph node (PLN) radiotherapy. Despite the independent motion of the prostate from bone, recent study has demonstrated that adequate dose could be delivered to this target when a 10mm margin except 7mm posteriorly is used to expand the PTV. This study explored the feasibility of reducing the margin by assessing the dosimetric impact on prostate and organ at risks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
